Astanor leads series-A round for Hyris
Astanor Ventures has led a series-A funding round for biotechnology startup Hyris.
The funding round is said to have raised €2.5m for the company. The round was oversubscribed, according to a statement.
Astanor is an impact investor in the agriculture technology sector. Italian investors, including Neos Medica, IDB Holding – the holding company controlling Indena – and Pi Campus also participated.
The capital will go towards sales and marketing of the product.
Company
Based in London and founded in 2014, Hyris offers DNA testing for food quality assurance.
People
Astantor Ventures – George Coelho (co-founder, partner).
Hyris – Stefano Lo Priore (founder, CEO).
Advisers
Equity – Withers Worldwide (legal).
Company – Cross Border Growth Capital, Fabio Mondini de Focatiis (corporate finance); TLT (legal); Legance (legal).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds









